Driehaus Capital Management’s Auspex Pharmaceuticals ASPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-69,085
Closed -$6.93M – 657
2015
Q1
$6.93M Buy
69,085
+407
+0.6% +$27.1K 0.24% 105
2014
Q4
$3.6M Buy
68,678
+1,938
+3% +$56.9K 0.15% 195
2014
Q3
$1.71M Sell
66,740
-49,288
-42% -$1.05M 0.07% 356
2014
Q2
$2.58M Buy
116,028
+13,476
+13% +$295K 0.08% 302
2014
Q1
$3.15M Buy
+102,552
New +$2.76M 0.1% 253

Driehaus Capital Management's ASPX Position: Q2 2015 in Review

Driehaus Capital Management sold out of Auspex Pharmaceuticals (ASPX) in Q2 2015, closing a stake of 69,085 shares — an estimated $6.93M sold.

Driehaus Capital Management first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $6.93M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Driehaus Capital Management reported no remaining Auspex Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Driehaus Capital Management sold 69,085 Auspex Pharmaceuticals shares in Q2 2015, an estimated $6.93M.
  • Driehaus Capital Management first reported a position in Auspex Pharmaceuticals in Q1 2014 and held it in 5 quarters.
  • Driehaus Capital Management's Auspex Pharmaceuticals position peaked at $6.93M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Auspex Pharmaceuticals as of Q2 2015.

Based on Driehaus Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.